HF1183 Summary

• Prohibits manufacturers from imposing excessive price increases on generic or off-patent drugs sold in Minnesota, defined as increases exceeding 15% annually or 40% over three years (adjusted for inflation), or exceeding $30 for a 30-day supply or short course of treatment.

• Requires drug manufacturers selling generic or off-patent drugs in Minnesota to maintain a registered agent and office within the state.

• Authorizes the attorney general to investigate price violations, compel manufacturers to submit drug cost statements, and seek court orders for price restoration, consumer reimbursement, and civil penalties up to $10,000 per violation.

• Prohibits manufacturers from withdrawing generic or off-patent drugs from sale to avoid price increase restrictions, requiring 180 days' notice to the Board of Pharmacy and attorney general, with a $500,000 penalty for noncompliance.

• Amends pharmacy licensing disciplinary provisions to establish violations of the excessive price increase prohibitions as grounds for disciplinary action by the Board of Pharmacy and allows civil penalties up to $25,000 per violation.